Related Experiment Video
Updated: Jun 27, 2026
08:12
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
Published on: December 22, 2016
Humanized Mouse Model of Cooley's Anemia
Yongliang Huo1, Sean C McConnell, Shan-Run Liu
1Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
The Journal of Biological Chemistry
|December 23, 2008
Summary
Researchers created a new mouse model for Cooley's Anemia (CA) by modifying genes. This model mimics human CA, allowing for the study and testing of potential therapies for this blood disorder.
Area of Science:
- Genetics
- Hematology
- Animal Models
Background:
- Cooley's Anemia (CA) is a severe form of beta-thalassemia.
- Existing animal models do not fully recapitulate human CA pathophysiology.
Purpose of the Study:
- To develop a novel humanized mouse model for Cooley's Anemia.
- To create a preclinical platform for studying CA and evaluating therapeutic strategies.
Main Methods:
- Targeted gene replacement in embryonic stem (ES) cells to insert a human gamma to beta(0) globin gene cassette.
- Mutation introduced in the splice donor site of the human beta(0) globin allele to mimic human CA.
- Generation of heterozygous and homozygous gammabeta(0) mice, and crossbreeding with human alpha globin knockin mice.
Main Results:
- The novel mouse model exhibits microcytic anemia in heterozygous and homozygous forms.
- Homozygous mice demonstrate a switch to human fetal gamma globin during fetal development.
- Homozygous CA mice, when bred with human alpha globin knockin mice, survive solely on human fetal hemoglobin post-birth.
Conclusions:
- This humanized mouse model accurately reflects key aspects of Cooley's Anemia.
- The model serves as a valuable preclinical tool for investigating globin gene regulation and testing novel therapies for CA.
